Latest news

Clinical

Cloudbreak Pharma’s CBT-001 Meets Phase 3 Endpoints in Pterygium Trial

Cloudbreak Pharma has reported statistically significant improvements in both primary endpoints of its Phase 3 trial evaluating CBT-001, an...
Commercial

Evommune Secures Huge Hinova Deal for Oral Autoimmune Drug

Evommune has struck a licensing agreement with China-based Hinova Pharmaceuticals worth up to approximately $1.1 billion, giving the California...
Insights

Top 10 Drug Discovery Platforms to Watch

Executive Summary Artificial intelligence is changing how pharmaceutical companies identify drug targets, design molecules, evaluate therapeutic candidates, and prioritize research...
Insights

Launch Excellence in the Digital Era

Executive Summary Launching a pharmaceutical product has become increasingly complex. Scientific innovation alone does not guarantee commercial success. Market access...
Insights

Spatial Biology and Its Commercial Potential

Executive Summary Spatial biology is emerging as an important capability...
Commercial

Novartis Leaves $800M Neuro Partnership, Leaving BioArctic High And Dry

The pharmaceutical industry has lost another potential neuroscience development...
Clinical

Neurocrine Plans Vykat Safety Study After Reports of Patient Deaths

Neurocrine Biosciences plans to conduct a new study in 2027 to examine dosing and safety of its Prader-Willi syndrome...
Commercial

Just two months after entering the clinic, Sanofi removes the STAT6 degrader from Nurix

Sanofi has decided to end work on a STAT6 degrader from Nurix just two months after taking the inflammatory...
Insights

Top 10 Technologies Improving Patient Retention

Executive Summary Maintaining patient engagement throughout treatment is a growing priority for pharmaceutical companies and healthcare providers. Patients may discontinue...
Insights

Building AI-Ready Data Platforms in Life Sciences

Executive Summary Artificial intelligence is becoming central to pharmaceutical research,...
Clinical

Phase 3 psoriasis victory: China’s InventisBio provides competitive TYK2 data

Phase 3 Success and Primary Endpoint Achieved InventisBio's nomelcitinib met...
Clinical

Teva Discontinues Phase 2 Emrusolmin Trial for Multiple System Atrophy

Teva Pharmaceuticals is discontinuing its Phase 2 clinical trial of emrusolmin, an experimental oral drug being investigated for multiple...
Insights

Top 10 Digital Capabilities Separating Industry Leaders

Executive Summary Digital maturity is becoming a competitive differentiator across the pharmaceutical and biotechnology industries. While many organizations invest in...
Commercial

Astellas wagers $1.3 billion on Audax’s preclinical effort to end decades of IL-12 problems

Financial Terms and Partnership Scope Astellas has agreed to up to $285 million in upfront and option payments to get...
Commercial

Life Sciences Voice In Collaboration With Future Pharma EU 2026

Future Pharma Europe returns on 20–21 October 2026 in...
Editorial Team -
Commercial

Evommune Secures Huge Hinova Deal for Oral Autoimmune Drug

Evommune has struck a licensing agreement with China-based Hinova...
Editorial Team -
Commercial

New Player Latigo in Pain Biotech Challenges Vertex

A new contender has emerged in the domain of...
Commercial

U.S. to buy additional $1B of Merck’s Covid-19 drug

In the latest Merck’s COVID-19 news, it was reported...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Vera Health Raises $28.5 Million to Expand Clinical AI Search Platform

Vera Health, a clinical artificial intelligence search engine, has secured $28.5 million in Series...
Editorial Team -

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Regulatory

Regulatory

GSK’s Hepatitis B Drug Gets FDA Green Light

GSK has secured U.S. approval for bepirovirsen, an antisense...
Editorial Team -
Commercial

Evommune Secures Huge Hinova Deal for Oral Autoimmune Drug

Evommune has struck a licensing agreement with China-based Hinova...
Insights

Top 10 Drug Discovery Platforms to Watch

Executive Summary Artificial intelligence is changing how pharmaceutical companies identify...
Insights

Launch Excellence in the Digital Era

Executive Summary Launching a pharmaceutical product has become increasingly complex....
Insights

Top 10 Factors That Determine the Success of a Drug Candidate

Executive Summary A promising drug candidate must overcome multiple scientific,...

Research & Development

Market Access

Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Manufacturing

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

The Roche subsidiary has just announced that the restructuring...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

Cloudbreak Pharma’s CBT-001 Meets Phase 3 Endpoints in Pterygium Trial

Cloudbreak Pharma has reported statistically significant improvements in both...
Editorial Team -
Insights

Top 10 Drug Discovery Platforms to Watch

Executive Summary Artificial intelligence is changing how pharmaceutical companies identify...
Editorial Team -